iSpecimen Inc
NASDAQ:ISPC
iSpecimen Inc
NASDAQ:ISPC
Price:
0.263 USD
-1.31%
Market Closed
Updated:
May 4, 2024
iSpecimen Inc
Cash from Operating Activities
|
iSpecimen Inc
Cash from Operating Activities Peer Comparison
Comparables:
VEEV
INSP
EVH
DOCS
CERT
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
iSpecimen Inc
NASDAQ:ISPC
|
Cash from Operating Activities
-$5.8m
|
CAGR 3-Years
-172%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
|
Veeva Systems Inc
NYSE:VEEV
|
Cash from Operating Activities
$911.3m
|
CAGR 3-Years
18%
|
CAGR 5-Years
24%
|
CAGR 10-Years
36%
|
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Cash from Operating Activities
$24.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Evolent Health Inc
NYSE:EVH
|
Cash from Operating Activities
$142.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Doximity Inc
NYSE:DOCS
|
Cash from Operating Activities
$179.6m
|
CAGR 3-Years
90%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Certara Inc
NASDAQ:CERT
|
Cash from Operating Activities
$82.8m
|
CAGR 3-Years
23%
|
CAGR 5-Years
48%
|
CAGR 10-Years
N/A
|
See Also
What is iSpecimen Inc's Cash from Operating Activities?
Cash from Operating Activities
-5.8m
USD
-5.8m
USD
Based on the financial report for Dec 31, 2023, iSpecimen Inc's Cash from Operating Activities amounts to -5.8m USD.
What is iSpecimen Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-17%
-17%
Over the last year, the Cash from Operating Activities growth was 0%. The average annual Cash from Operating Activities growth rates for iSpecimen Inc have been -172% over the past three years , -17% over the past five years .
You don't have any saved screeners yet
